Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Polypeptide-chelating agent complexes reported by Novartis

Jan. 5, 1998

New photodynamic agents reported by Novartis

Dec. 31, 1997

Salagen Tablets enters phase III development in Japan

Dec. 30, 1997

Merck continues to pursue peptidomimetic farnesyltransferase inhibitors

Dec. 30, 1997

VRCTC-310: MTD, preliminary efficacy and pharmacokinetic data in humans

Dec. 29, 1997

SAR leading to new topoisomerase I inhibitor presented by Banyu

Dec. 29, 1997

Peptidomimetic protein farnesyltransferase inhibitors in development at Merck

Dec. 24, 1997

ICI-182780 associated with longer remission duration than megestrol in resistant breast cancer

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Squalamine enters phase I for the treatment of cancer

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....